Cubist Pharmaceuticals Inc (NASDAQ:CBST)

69.03
Data as of Aug 29
 +0.12 / +0.17%
Today’s Change
58.50
Today|||52-Week Range
82.12
+0.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$5.2B

Company Description

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Its products and product candidates are used in hospitals and other acute care settings, including home infusion and hospital outpatient clinics. The company was founded in 1992 and is headquartered in Lexington, MA.

Contact Information

Cubist Pharmaceuticals, Inc.
65 Hayden Avenue
Lexington Massachusetts 02421-7994
P:(781) 860-8660
Investor Relations:
(781) 860-8100

Employees

Shareholders

Mutual fund holders65.38%
Other institutional39.48%
Individual stakeholders1.14%

Top Executives

Michael W. BonneyChief Executive Officer & Director
Robert J. PerezPresident, Chief Operating Officer & Director
Michael John TomsicekChief Financial Officer & Senior Vice President
Edward S. CampanaroVP-Clinical Operations & Data Management
Barry I. EisensteinSenior Vice President-Scientific Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.